JF
ALXO icon

Jump Financial’s ALX Oncology ALXO Stock Holding History

Jump Financial’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-140,000
Closed -$844K – 1610
2024
Q2 		$844K Buy
140,000
+115,194
+464% +$1.42M 0.02% 899
2024
Q1 		$277K Sell
24,806
-140
-0.6% -$1.97K 0.01% 1485
2023
Q4 		$371K Buy
+24,946
New +$237K 0.01% 1219
2023
Q1 		– Sell
-14,742
Closed -$166K – 1546
2022
Q4 		$166K Sell
14,742
-14,158
-49% -$159K 0.01% 1337
2022
Q3 		$277K Sell
28,900
-9,800
-25% -$114K 0.01% 1191
2022
Q2 		$313K Sell
38,700
-600
-2% -$6.53K 0.01% 1039
2022
Q1 		$664K Sell
39,300
-3,136
-7% -$53.5K 0.03% 686
2021
Q4 		$912K Buy
+42,436
New +$1.83M 0.06% 421

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's ALXO Position: Q3 2024 in Review

Jump Financial sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 140,000 shares — an estimated $844K sold.

Jump Financial first reported a position in ALXO in Q4 2021 and held it in 8 quarters. The position peaked at $912K in Q4 2021. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Jump Financial reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 140,000 ALX Oncology shares in Q3 2024, an estimated $844K.
  • Jump Financial first reported a position in ALX Oncology in Q4 2021 and held it in 8 quarters.
  • Jump Financial's ALX Oncology position peaked at $912K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.